Jefferies Downgrades BridgeBio Pharma (BBIO) to Hold

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/13/2026

1. CSCO
2. CBRS
3. COHR
4. SPY
5. WYFI
6. STUB
7. EAT
8. BTGO
9. NVDA
10. GO

July 18, 2023 2:31 AM EDT
Get Alerts BBIO Hot Sheet
Price: $81.21 -3.14%

Rating Summary:
    25 Buy, 3 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 19 | Down: 16 | New: 9
Join SI Premium – FREE

Jefferies analyst Eun Yang downgraded BridgeBio Pharma (NASDAQ: BBIO) from Buy to Hold with a price target of $33.00 (from $24.00).


For an analyst ratings summary and ratings history on BridgeBio Pharma click here. For more ratings news on BridgeBio Pharma click here.


Shares of BridgeBio Pharma closed at $32.04 yesterday.


You May Also Be Interested In





Related Categories

Analyst PT Change, Downgrades